Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults.

Bowman GL, Dayon L, Kirkland R, Wojcik J, Peyratout G, Severin IC, Henry H, Oikonomidi A, Migliavacca E, Bacher M, Popp J.

Alzheimers Dement. 2018 Aug 8. pii: S1552-5260(18)33035-8. doi: 10.1016/j.jalz.2018.06.2857. [Epub ahead of print]

PMID:
30120040
2.

Alzheimer disease pathology and the cerebrospinal fluid proteome.

Dayon L, Núñez Galindo A, Wojcik J, Cominetti O, Corthésy J, Oikonomidi A, Henry H, Kussmann M, Migliavacca E, Severin I, Bowman GL, Popp J.

Alzheimers Res Ther. 2018 Jul 18;10(1):66. doi: 10.1186/s13195-018-0397-4.

3.

Cross-Sectional Associations of Total Plasma Homocysteine with Cortical β-Amyloid Independently and as a Function of Omega 3 Polyunsaturated Fatty Acid Status in Older Adults at Risk of Dementia.

Hooper C, De Souto Barreto P, Coley N, Caussé E, Payoux P, Salabert AS, Cesari M, Andrieu S, Bowman GL, Weiner M, Vellas B.

J Nutr Health Aging. 2017;21(10):1075-1080. doi: 10.1007/s12603-017-0989-x.

PMID:
29188863
4.

Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.

Dayon L, Wojcik J, Núñez Galindo A, Corthésy J, Cominetti O, Oikonomidi A, Henry H, Migliavacca E, Bowman GL, Popp J.

J Alzheimers Dis. 2017;60(4):1641-1652. doi: 10.3233/JAD-170426.

5.

Biomarkers for early detection of Parkinson disease: A scent of consistency with olfactory dysfunction.

Bowman GL.

Neurology. 2017 Oct 3;89(14):1432-1434. doi: 10.1212/WNL.0000000000004383. Epub 2017 Sep 6. No abstract available.

PMID:
28878052
6.

One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond.

Dayon L, Guiraud SP, Corthésy J, Da Silva L, Migliavacca E, Tautvydaitė D, Oikonomidi A, Moullet B, Henry H, Métairon S, Marquis J, Descombes P, Collino S, Martin FJ, Montoliu I, Kussmann M, Wojcik J, Bowman GL, Popp J.

Alzheimers Res Ther. 2017 Jun 17;9(1):43. doi: 10.1186/s13195-017-0270-x.

7.

Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.

Popp J, Oikonomidi A, Tautvydaitė D, Dayon L, Bacher M, Migliavacca E, Henry H, Kirkland R, Severin I, Wojcik J, Bowman GL.

Brain Behav Immun. 2017 May;62:203-211. doi: 10.1016/j.bbi.2017.01.020. Epub 2017 Feb 1.

8.

Nutrition for the ageing brain: Towards evidence for an optimal diet.

Vauzour D, Camprubi-Robles M, Miquel-Kergoat S, Andres-Lacueva C, Bánáti D, Barberger-Gateau P, Bowman GL, Caberlotto L, Clarke R, Hogervorst E, Kiliaan AJ, Lucca U, Manach C, Minihane AM, Mitchell ES, Perneczky R, Perry H, Roussel AM, Schuermans J, Sijben J, Spencer JP, Thuret S, van de Rest O, Vandewoude M, Wesnes K, Williams RJ, Williams RS, Ramirez M.

Ageing Res Rev. 2017 May;35:222-240. doi: 10.1016/j.arr.2016.09.010. Epub 2016 Oct 3. Review.

9.

Ascorbic acid and the brain: rationale for the use against cognitive decline.

Harrison FE, Bowman GL, Polidori MC.

Nutrients. 2014 Apr 24;6(4):1752-81. doi: 10.3390/nu6041752. Review.

10.

Plasma omega-3 PUFA and white matter mediated executive decline in older adults.

Bowman GL, Dodge HH, Mattek N, Barbey AK, Silbert LC, Shinto L, Howieson DB, Kaye JA, Quinn JF.

Front Aging Neurosci. 2013 Dec 16;5:92. doi: 10.3389/fnagi.2013.00092. eCollection 2013.

11.

Memory, mood, and vitamin D in persons with Parkinson's disease.

Peterson AL, Murchison C, Zabetian C, Leverenz JB, Watson GS, Montine T, Carney N, Bowman GL, Edwards K, Quinn JF.

J Parkinsons Dis. 2013;3(4):547-55. doi: 10.3233/JPD-130206.

12.

Serum vitamin D concentrations are associated with falling and cognitive function in older adults.

Peterson A, Mattek N, Clemons A, Bowman GL, Buracchio T, Kaye J, Quinn J.

J Nutr Health Aging. 2012 Oct;16(10):898-901. doi: 10.1007/s12603-012-0378-4.

13.

Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease.

Bowman GL, Kaye JA, Quinn JF.

Curr Gerontol Geriatr Res. 2012;2012:184042. doi: 10.1155/2012/184042. Epub 2012 May 13.

14.

Ascorbic acid, cognitive function, and Alzheimer's disease: a current review and future direction.

Bowman GL.

Biofactors. 2012 Mar-Apr;38(2):114-22. doi: 10.1002/biof.1002. Epub 2012 Mar 15. Review.

15.

Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging.

Bowman GL, Silbert LC, Howieson D, Dodge HH, Traber MG, Frei B, Kaye JA, Shannon J, Quinn JF.

Neurology. 2012 Jan 24;78(4):241-9. doi: 10.1212/WNL.0b013e3182436598. Epub 2011 Dec 28.

16.

Reliability and validity of food frequency questionnaire and nutrient biomarkers in elders with and without mild cognitive impairment.

Bowman GL, Shannon J, Ho E, Traber MG, Frei B, Oken BS, Kaye JA, Quinn JF.

Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):49-57. doi: 10.1097/WAD.0b013e3181f333d6.

17.

Comparisons of plasma/serum micronutrients between Okinawan and Oregonian elders: a pilot study.

Dodge HH, Katsumata Y, Todoriki H, Yasura S, Willcox DC, Bowman GL, Willcox B, Leonard S, Clemons A, Oken BS, Kaye JA, Traber MG.

J Gerontol A Biol Sci Med Sci. 2010 Oct;65(10):1060-7. doi: 10.1093/gerona/glq124. Epub 2010 Jul 19.

18.

Uric acid as a CNS antioxidant.

Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF.

J Alzheimers Dis. 2010;19(4):1331-6. doi: 10.3233/JAD-2010-1330.

19.

Ascorbic acid and rates of cognitive decline in Alzheimer's disease.

Bowman GL, Dodge H, Frei B, Calabrese C, Oken BS, Kaye JA, Quinn JF.

J Alzheimers Dis. 2009;16(1):93-8. doi: 10.3233/JAD-2009-0923.

20.

Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future.

Bowman GL, Quinn JF.

Aging health. 2008 Feb 1;4(1):47-55. No abstract available.

21.

Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.

Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF.

Neurology. 2007 May 22;68(21):1809-14.

22.
23.
24.

Costs associated with selected preventive practices and with episodes of clinical mastitis in nine herds with low somatic cell counts.

Hoblet KH, Schnitkey GD, Arbaugh D, Hogan JS, Smith KL, Schoenberger PS, Todhunter DA, Hueston WD, Pritchard DE, Bowman GL, et al.

J Am Vet Med Assoc. 1991 Jul 15;199(2):190-6.

PMID:
1890027
25.

Field survey of clinical mastitis in low somatic cell count herds.

Hogan JS, Smith KL, Hoblet KH, Schoenberger PS, Todhunter DA, Hueston WD, Pritchard DE, Bowman GL, Heider LE, Brockett BL, et al.

J Dairy Sci. 1989 Jun;72(6):1547-56.

PMID:
2760314
26.

Bacterial counts in bedding materials used on nine commercial dairies.

Hogan JS, Smith KL, Hoblet KH, Todhunter DA, Schoenberger PS, Hueston WD, Pritchard DE, Bowman GL, Heider LE, Brockett BL, et al.

J Dairy Sci. 1989 Jan;72(1):250-8.

PMID:
2925950
27.

Serratia liquefaciens mastitis in a dairy herd.

Bowman GL, Hueston WD, Boner GJ, Hurley JJ, Andreas JE.

J Am Vet Med Assoc. 1986 Oct 15;189(8):913-5.

PMID:
3771362

Supplemental Content

Loading ...
Support Center